Welcome to our dedicated page for EXELON SEC filings (Ticker: EXC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on EXELON's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into EXELON's regulatory disclosures and financial reporting.
Form 4 filing for Exelon Corp. (EXC) discloses that director William P. Bowers increased his equity exposure on 30 June 2025.
- Deferred stock units: 954 units acquired at $43.25 each through the Exelon Directors Deferred Stock Unit Plan, lifting his indirect balance to 16,734 units.
- Phantom share equivalents: 1,594 equivalents credited at an implied price of $43.42, bringing his direct derivative balance to 15,163 equivalents.
- The filing notes an additional 145 common shares and 121 phantom equivalents previously added via the plan’s dividend-reinvestment mechanism.
- All phantom equivalents settle for cash on a 1-for-1 basis when Bowers leaves the board.
No open-market purchases or sales were reported; the activity stems from board compensation and reinvestment features.
Exelon Corporation (NASDAQ: EXC) has filed an amended prospectus supplement for its Direct Stock Purchase Plan, with changes effective August 1, 2025. The plan offers investors a convenient method to purchase common stock and reinvest dividends.
Key Plan Features:
- Initial investment minimum: $250 for new investors
- Monthly investment maximum: $20,000
- Dividend reinvestment options: Full or partial
- Initial enrollment fee: $15 for new investors
- Dividend reinvestment fee: 3% (maximum $3)
- Trading commissions: $0.07 per share for purchases, $0.12 for sales
The plan offers multiple investment options including one-time purchases, recurring automatic investments, and dividend reinvestment. Trading fees vary by order type, ranging from $15 for batch orders to $30 for limit/stop orders. Company-paid services include check investments, automatic investments, and certificate deposits.